Inovio Pharmaceuticals
INO
#9344
Rank
NZ$0.18 B
Marketcap
NZ$2.30
Share price
1.50%
Change (1 day)
-31.16%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.90. In 2024 the company made an earnings per share (EPS) of NZ-$6.72 an increase over its 2023 EPS that were of NZ-$10.37.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-28.55%
2024NZ-$6.72-35.14%
2023NZ-$10.37-56.62%
2022NZ-$23.90-19.54%
2021NZ-$29.7035.9%
2020NZ-$21.86-11.57%
2019NZ-$24.7215.24%
2018NZ-$21.45-2.78%
2017NZ-$22.066.93%
2016NZ-$20.63134.88%
2015NZ-$8.78-29.51%
2014NZ-$12.46-57.34%
2013NZ-$29.21146.55%
2012NZ-$11.8520.83%
2011NZ-$9.80-29.41%
2010NZ-$13.89-48.48%
2009NZ-$26.9610%
2008NZ-$24.5111.11%
2007NZ-$22.06-41.3%
2006NZ-$37.58-66.91%
2005NZ-$113.57110.61%
2004NZ-$53.93-61.63%
2003NZ-$140.53186.67%
2002NZ-$49.02
2001N/A-100%
2000NZ-$39.22-63.64%
1999NZ-$107.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.87-403.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.95-343.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.23-145.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.66-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.06-223.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.62-234.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ$0.60-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA